Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt No Debt
EGLT's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: No Debt )
EGLT' s 10-Year Cash to Debt Range
Min: 0.91   Max: No Debt
Current: No Debt

Equity to Asset 0.85
EGLT's Equity to Asset is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 0.85 )
EGLT' s 10-Year Equity to Asset Range
Min: 0.85   Max: 0.85
Current: 0.85

Z-Score: 2.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
ROA (%) -99.23
EGLT's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: -99.23 )
EGLT' s 10-Year ROA (%) Range
Min: -307.77   Max: -96.51
Current: -99.23

-307.77
-96.51
ROC (Joel Greenblatt) (%) -469.01
EGLT's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: -469.01 )
EGLT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -906.13   Max: -469.01
Current: -469.01

-906.13
-469.01
» EGLT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

EGLT Guru Trades in

EGLT Guru Trades in

EGLT Guru Trades in

Q1 2014

EGLT Guru Trades in Q1 2014

Steven Cohen 31,594 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with EGLT



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 3.00
EGLT's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 3.00 )
EGLT' s 10-Year P/B Range
Min: 0   Max: 3.8
Current: 3

0
3.8
P/S 168.70
EGLT's P/S is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 168.70 )
EGLT' s 10-Year P/S Range
Min: 0   Max: 200.7
Current: 168.7

0
200.7
EV-to-EBIT -11.79
EGLT's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: -11.79 )
EGLT' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -11.79

Current Ratio 29.19
EGLT's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 29.19 )
EGLT' s 10-Year Current Ratio Range
Min: 0.59   Max: 29.19
Current: 29.19

0.59
29.19
Quick Ratio 29.19
EGLT's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 29.19 )
EGLT' s 10-Year Quick Ratio Range
Min: 0.59   Max: 29.19
Current: 29.19

0.59
29.19

Valuation & Return

vs
industry
vs
history
Price/Net Cash 3.10
EGLT's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 3.10 )
EGLT' s 10-Year Price/Net Cash Range
Min: 3.63   Max: 3.63
Current: 3.1

Price/Net Current Asset Value 3.10
EGLT's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 3.10 )
EGLT' s 10-Year Price/Net Current Asset Value Range
Min: 3.62   Max: 3.62
Current: 3.1

Price/Tangible Book 3.00
EGLT's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. EGLT: 3.00 )
EGLT' s 10-Year Price/Tangible Book Range
Min: 3.45   Max: 3.45
Current: 3

Business Description

Industry: »
Compare: » details
» More Articles for EGLT

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Nasdaq stocks posting largest percentage decreases Jul 23 2014
Nasdaq stocks posting largest percentage decreases Jul 23 2014
EGALET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 15 2014
Egalet reports positive top-line results from Category 1 abuse deterrence study Jul 15 2014
Egalet Reports Positive Top-Line Results From Category 1 Abuse Deterrence Studies Demonstrating... Jul 15 2014
EGALET CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial... Jun 10 2014
EGALET CORP Financials May 23 2014
Egalet to Present at Upcoming Investor Conferences in June May 22 2014
EGALET CORP Files SEC form 10-Q, Quarterly Report May 15 2014
EGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 13 2014
Q2 2014 Egalet Corp Earnings Release - Before Market Open May 13 2014
Egalet Reports First Quarter 2014 Financial Results and Provides Business Update May 13 2014
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May... Apr 29 2014
Egalet Corporation [EGLT] to Ring The NASDAQ Stock Market Opening Bell Apr 23 2014
EGALET CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 31 2014
Danish drug maker Santaris considers U.S. listing -investor Mar 26 2014
EGALET CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 26 2014
Egalet Reports Full Year 2013 Financial Results and Provides Business Update Mar 26 2014
Egalet Reports Full Year 2013 Financial Results and Provides Business Update Mar 26 2014
Egalet Initiates Bioequivalence Studies for Abuse-Deterrent Morphine Egalet-001 Mar 25 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide